Quality & Compliance

Built for Regulated Environments

TurboPlatform is architected for GLP and non-GLP nonclinical environments where data integrity, traceability, and validation discipline are foundational requirements.

Quality and compliance are not layered on after development. They are embedded within the platform architecture.

The objective is structural compliance, not procedural compensation.

GLP

Architected to support GLP-compliant nonclinical study execution with integrated traceability from protocol through reporting and SEND.

21 CFR Part 11

Electronic records and signatures are managed within a secure, audit-trailed framework aligned with 21 CFR Part 11 expectations for trustworthiness and reliability.

Validation

TurboPlatform consolidates validation within a unified architectural framework, reducing fragmented requalification effort and supporting scalable regulatory oversight.

SEND 4.0

Designed for structural SEND modernization, integrating controlled terminology, data lineage, and lifecycle-driven architecture rather than reactive file mapping.

Transition and Migration Methodology

Modernization must not disrupt regulatory continuity. TurboPlatform deployment includes:

Legacy data-migration planning

Controlled terminology harmonization

Validation-impact assessment

Parallel-run strategies where required

Structured cutover planning

The objective is controlled modernization, not disruptive replacement.

Long-Term Compliance Sustainability

Regulatory expectations evolve. TurboPlatform is designed to adapt within its architectural
foundation rather than relying on reactive retrofits.

SEND 4.0 modernization

Controlled terminology updates

Emerging data standards

Evolving documentation expectations

Compliance sustainability is structural, not episodic.

Confidence Through Architecture

Quality and compliance are not achieved through policy statements. They are achieved
through architecture.

TurboPlatform provides a unified, validated foundation designed to support scientific advancement
without increasing regulatory exposure.